biologics

Predictive Oncology , a science-driven company on the leading edge of oncology drug discovery and development, announces it is partnering with Integra…

PA an advanced biotherapeutic research and technology company, announced that BioStrand BV (“BioStrand”), an AI in silico discovery subsidiary of IPA,…

Fast and accurate generative AI design of novel antibodies extends Exscientia's capabilities beyond small molecules Sequencing paired human…

- Genexine to focus on global drug development and commercialization - Near term milestones should drive shareholder value - Renewed effort to…

-- Writing the Future of Biologics Presentation on May 2 -- -- Rapid, Function-Forward mAb Discovery against a Cell Surface Target via…

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced it has resubmitted the…

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the U.S. Food and…

Hansa expects to complete enrollment in the second half of 2022 with a 12-month follow up completed in the second half of 2023 The U.S. randomized,…

WuXi Biologics, a global company with leading open-access biologics technology platforms, and ImmuneOncia Therapeutics, Inc., a clinical-stage,…

Strengthens leadership in USA   Alex Del Priore appointed as Senior Vice President, Manufacturing Services Alan Collis appointed as Vice…